Alkermes’ clinical trials are important milestones on the path to discovering new therapies that may address significant unmet medical needs for patients. Keeping physicians, patients and caregivers up-to-date about such studies is one of our top priorities.

On this page, you can find links to information about studies that are sponsored by Alkermes or our partners. For additional information about clinical trials using Alkermes’ products or development candidates, sponsored by Alkermes or other institutions, consult the National Institute of Health website, www.clinicaltrials.gov, which contains a searchable database. A summary of completed studies can be found at www.clinicalstudyresults.org.

Central Nervous System (CNS)

Addiction

Efficacy and Safety of VIVITROL® in Adults With Opioid Dependence

A Safety Study of VIVITROL Administered to Healthcare Professionals

Efficacy and Safety of VIVITROL After Enforced Abstinence

Study of the Effects of VIVITROL on Craving Using Functional MRI (fMRI)

VIVITROL as a Treatment for Cocaine and Alcohol Dependence  

A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence 

A Study of RDC-0313 Administered to Healthy Adults



Other Mental Health

Evaluation of Effectiveness of RISPERDAL® CONSTA® Compared to Abilify® Over a Two-Year Period in Patients With Schizophrenia

Long-Acting Injectable Risperidone in Post-Acute Schizophrenia

A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres

Follow up of Schizophrenic Patients Following Treatment Discontinuation After Remission From a First Psychotic Episode

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center


Diabetes

A Study to Evaluate the Glycemic Effects, Safety and Tolerability of Exenatide Once Weekly in Subjects with Type 2 Diabetes Meillitus (DURATION-5)

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION-3)

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Treated With Metformin (DURATION-2)

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus (DURATION-1)

A Study to Examine the Pharmacokinetics, Tolerability and Safety of Exenatide Once Weekly Suspension